Evidence map›Paper›PMID 38506088›Full record

ArticleNanoscale2024

Alternative nano-lithographic tools for shell-isolated nanoparticle enhanced Raman spectroscopy substrates.

Ketki Srivastava, Thimo S Jacobs, Stefan Ostendorp, Dirk Jonker, Floor A Brzesowsky, Arturo Susarrey-Arce, Han Gardeniers, Gerhard Wilde, Bert M Weckhuysen, Albert van den Berg and 2 more

Abstract read
In one paragraph

Article in Nanoscale, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Blue light activated nitrogen doped poly floral carbon quantum dots: multifunctional agent for anti-microbial and anti-cancer photodynamic therapy.Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Ketki SrivastavaBIOS Lab on Chip Group, Mesa+ Institute of Nanotechnology, University of Twente, The Netherlands. m.odijk@utwente.nl.ORCID http://orcid.org/0000-0002-3774-5490
Thimo S JacobsInorganic Chemistry and Catalysis group, Debye Institute for Nanomaterials Science and Institute for Sustainable and Circular Chemistry, Utrecht University, The Netherlands. w.vanderstam@uu.nl.ORCID http://orcid.org/0000-0002-4863-8105
Stefan OstendorpInstitute of Materials Physics, University of Münster, Germany.
Dirk JonkerMesoscale Chemical Systems, Mesa+ Institute of Nanotechnology, University of Twente, The Netherlands.ORCID http://orcid.org/0000-0003-0904-7545
Floor A BrzesowskyInorganic Chemistry and Catalysis group, Debye Institute for Nanomaterials Science and Institute for Sustainable and Circular Chemistry, Utrecht University, The Netherlands. w.vanderstam@uu.nl.
Arturo Susarrey-ArceMesoscale Chemical Systems, Mesa+ Institute of Nanotechnology, University of Twente, The Netherlands.ORCID http://orcid.org/0000-0003-2572-223X
Han GardeniersMesoscale Chemical Systems, Mesa+ Institute of Nanotechnology, University of Twente, The Netherlands.ORCID http://orcid.org/0000-0003-0581-2668
Gerhard WildeInstitute of Materials Physics, University of Münster, Germany.
Bert M WeckhuysenInorganic Chemistry and Catalysis group, Debye Institute for Nanomaterials Science and Institute for Sustainable and Circular Chemistry, Utrecht University, The Netherlands. w.vanderstam@uu.nl.ORCID http://orcid.org/0000-0001-5245-1426
Albert van den BergBIOS Lab on Chip Group, Mesa+ Institute of Nanotechnology, University of Twente, The Netherlands. m.odijk@utwente.nl.ORCID http://orcid.org/0000-0001-9019-933X
Ward van der StamInorganic Chemistry and Catalysis group, Debye Institute for Nanomaterials Science and Institute for Sustainable and Circular Chemistry, Utrecht University, The Netherlands. w.vanderstam@uu.nl.ORCID http://orcid.org/0000-0001-8155-5400
Mathieu OdijkBIOS Lab on Chip Group, Mesa+ Institute of Nanotechnology, University of Twente, The Netherlands. m.odijk@utwente.nl.ORCID http://orcid.org/0000-0002-4467-9604

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chemically synthesized metal nanoparticles (MNPs) have been widely used as surface-enhanced Raman spectroscopy (SERS) substrates for monitoring catalytic reactions. In some applications, however, the SERS MNPs, besides being plasmonically active, can also be catalytically active and result in Raman signals from undesired side products. The MNPs are typically insulated with a thin (∼3 nm), in principle pin-hole-free shell to prevent this. This approach, which is known as shell-isolated nanoparticle-enhanced Raman spectroscopy (SHINERS), offers many advantages, such as better thermal and chemical stability of the plasmonic nanoparticle. However, having both a high enhancement factor and ensuring that the shell is pin-hole-free is challenging because there is a trade-off between the two when considering the shell thickness. So far in the literature, shell insulation has been successfully applied only to chemically synthesized MNPs. In this work, we alternatively study different combinations of chemical synthesis (bottom-up) and lithographic (top-down) routes to obtain shell-isolated plasmonic nanostructures that offer chemical sensing capabilities. The three approaches we study in this work include (1) chemically synthesized MNPs + chemical shell, (2) lithographic substrate + chemical shell, and (3) lithographic substrate + atomic layer deposition (ALD) shell. We find that ALD allows us to fabricate controllable and reproducible pin-hole-free shells. We showcase the ability to fabricate lithographic SHINER substrates which report an enhancement factor of 7.5 × 10

Identifiers

PMID38506088
PMCPMC11025715

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.